MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
1614.17%
Quick Ratio
1614.17%
Debt to Asset Ratio
6.20%
Unit: Dollar
Assets Breakdown
Cash
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Trade accounts payable and accru...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash
5,170,286
5,560,511
7,286,670
7,329,298
Prepaid expenses
195,618
229,025
54,691
72,819
Total current assets
5,365,904
5,789,536
7,341,361
7,402,117
Total assets
5,365,904
5,789,536
7,341,361
7,402,117
Trade accounts payable and accrued liabilities
195,526
279,615
536,769
329,375
Due to officer
-
-
155,518
-
Accrued compensation - officer
-
-
417,470
-
Insurance loan payable
136,372
202,869
-
-
Due to related parties
526
344,826
318,234
93,432
Total current liabilities
332,424
827,310
1,427,991
422,807
Total liabilities
332,424
827,310
1,427,991
422,807
Additional paid-in capital
48,756,018
46,963,236
46,923,433
45,928,180
Accumulated deficit
-43,722,538
-42,001,010
-41,010,063
-38,948,870
Total stockholders equity
5,033,480
4,962,226
5,913,370
6,979,310
Total liabilities and stockholders equity
5,365,904
5,789,536
7,341,361
7,402,117
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash
$5,170,286
(585.42%↑ Y/Y)
Prepaid expenses
$195,618
(159.83%↑ Y/Y)
Total current assets
$5,365,904
(546.80%↑ Y/Y)
Total assets
$5,365,904
(546.80%↑ Y/Y)
Total liabilities and
stockholders equity
$5,365,904
(546.80%↑ Y/Y)
Total stockholders
equity
$5,033,480
(945.98%↑ Y/Y)
Total liabilities
$332,424
(-4.58%↓ Y/Y)
Accumulated deficit
-$43,722,538
(-15.53%↓ Y/Y)
Additional paid-in capital
$48,756,018
(27.21%↑ Y/Y)
Total current
liabilities
$332,424
(-4.58%↓ Y/Y)
Trade accounts
payable and accrued...
$195,526
(-23.31%↓ Y/Y)
Insurance loan payable
$136,372
Due to related
parties
$526
(-99.44%↓ Y/Y)
Buy us a coffee
Telomir Pharmaceuticals, Inc. (TELO)
Telomir Pharmaceuticals, Inc. (TELO)